.png)
Qureight has appointed Patrick Driscoll as the company’s Chief Financial Officer, strengthening the company’s financial and operational capabilities.
Patrick brings extensive experience in finance and operations across healthcare, biotech, and engineering sectors in both the UK and North America. He has held leadership roles at VetCT Specialists, CN Bio Innovations, and Johnson Matthey, where he played a key role in scaling high-tech service, manufacturing, and research businesses from startups to listed companies.
“I’m thrilled to join Qureight at a time of growth and innovation,” Patrick said. “The company is making an important impact on clinical trials and drug development in lung and heart disease through application of its unique technology and world-leading domain expertise, and I am excited by the opportunity to help scale its operational and financial systems and processes to support its growth.”
Patrick holds a PhD in History from the University of Cambridge and is a Fellow of the ICAEW, having trained with Deloitte.
His expertise in building and managing financial and operational infrastructure will be instrumental in Qureight’s next phase of development.
Dr Muhunthan Thillai, Founder and CEO, Qureight, said:
“Patrick’s appointment marks a significant step forward for Qureight as we scale our global operations. His deep financial and operational expertise across techbio and healthcare sectors will be invaluable in building the robust infrastructure we need to support our next phase of expansion. As we continue to grow, Patrick’s leadership will help ensure we scale efficiently and sustainably.”